![Jean-Loup Romet-Lemonne](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Jean-Loup Romet-Lemonne
Direttore/Membro del Consiglio presso Antabio SAS
Profilo
Jean-Loup Romet-Lemonne is currently the Director at Antabio SAS.
Previously, he held the position of Director at Natural Implant SA. From 1993 to 2007, he was the Director at IDM Pharma, Inc. He also worked as a Professor at Harvard University.
Posizioni attive di Jean-Loup Romet-Lemonne
Società | Posizione | Inizio |
---|---|---|
Antabio SAS
![]() Antabio SAS Pharmaceuticals: MajorHealth Technology Antabio SAS operates as a biopharmaceutical company which develops drugs for the treatment and prevention of antibiotic-resistant bacterial infections. The firm focuses bacterial disease research, drug design, antibiotic combination testing, and in vitro technology development operations. The company was founded by Marc Lemonnier and Aymeric Dugray on October 15, 2009 and is headquartered in Labege, France. | Direttore/Membro del Consiglio | - |
Precedenti posizioni note di Jean-Loup Romet-Lemonne
Società | Posizione | Fine |
---|---|---|
IDM Pharma, Inc.
![]() IDM Pharma, Inc. Pharmaceuticals: MajorHealth Technology IDM Pharma, Inc. develops products for the destruction of cancer cells. Its products activate the immune system or prevent recurrence by triggering adaptive immune response. The company was founded in established on October 1987 and is headquartered in Cambridge, MA. | Direttore/Membro del Consiglio | 16/07/2007 |
Harvard University
![]() Harvard University Other Consumer ServicesConsumer Services Harvard University engages in the provision of teaching and research. It has twelve degree-granting Schools in addition to the Radcliffe Institute for Advanced Study, offering a global education. The university was founded in 1636 and is headquartered in Cambridge, MA. | Corporate Officer/Principal | - |
Natural Implant SA
![]() Natural Implant SA Medical SpecialtiesHealth Technology Natural Implant SA develops and manufactures dental implants from biomaterial. The company manufactures a novel type of dental implant made from an FDA biomaterial around which it grows periodontal ligament cells using tissue engineering techniques. Natural Implant was founded in 1998 and is headquartered in Brest, France. | Direttore/Membro del Consiglio | - |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Aziende private | 3 |
---|---|
Natural Implant SA
![]() Natural Implant SA Medical SpecialtiesHealth Technology Natural Implant SA develops and manufactures dental implants from biomaterial. The company manufactures a novel type of dental implant made from an FDA biomaterial around which it grows periodontal ligament cells using tissue engineering techniques. Natural Implant was founded in 1998 and is headquartered in Brest, France. | Health Technology |
IDM Pharma, Inc.
![]() IDM Pharma, Inc. Pharmaceuticals: MajorHealth Technology IDM Pharma, Inc. develops products for the destruction of cancer cells. Its products activate the immune system or prevent recurrence by triggering adaptive immune response. The company was founded in established on October 1987 and is headquartered in Cambridge, MA. | Health Technology |
Antabio SAS
![]() Antabio SAS Pharmaceuticals: MajorHealth Technology Antabio SAS operates as a biopharmaceutical company which develops drugs for the treatment and prevention of antibiotic-resistant bacterial infections. The firm focuses bacterial disease research, drug design, antibiotic combination testing, and in vitro technology development operations. The company was founded by Marc Lemonnier and Aymeric Dugray on October 15, 2009 and is headquartered in Labege, France. | Health Technology |
- Borsa valori
- Insiders
- Jean-Loup Romet-Lemonne